Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol hydrochloride inhalation solution for lower respiratory tract infection in children
CTR20130557Phase 3Active
- Sponsor
- Hanmi Pharmaceutical
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, acute bronchitis, chronic bronchitis (CB), asthmatic bronchitis, rhinosinusitis, sponsored by Hanmi Pharmaceutical. Started Oct 2013; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infectionacute bronchitischronic bronchitis (CB)asthmatic bronchitisrhinosinusitis
Beyond the preview
Go deeper on CTR20130557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130557.